February 16, 2021
SNP chips, a type of DNA microarray frequently employed by consumer genomics companies, are "extremely unreliable" when identifying clinically-relevant variants that are rare among the general population, according to a retrospective study recently published in The BMJ.
The investigation, conducted by researchers from the University of Exeter, reviewed sequencing data from nearly 50,000...
A product image of the existing AncestryHealth offering.
August 24, 2020
Consumer genomics company Ancestry recently received two FDA 510(k)s – one for an in vitro molecular test that detects genomic variants tied to potential disease risk, and another for a saliva-based DNA specimen-collection kit.
Both of these submissions were received by the FDA in October of last year, which officially cleared them on August 13, according to the agency's 510(k) database.
October 15, 2019
Ancestry, a consumer genomic testing company focused on family history, is now turning to the health space with its launch of AncestryHealth. The new product is aimed at giving customers insights into the health risks associated with their genes and family history.
As part of the new services customers can get tests that are ordered by doctors. The service will also provide education resources...
June 21, 2019
About the Authors: Joshua Barrett is a member of the 2019 Flare Capital Partners Scholar program and a third-year medical student at Georgetown University School of Medicine, who completed his MBA at the Columbia Business School. He plans to pursue a career in healthcare technology or life sciences investing.
Dr. Dan Gebremedhin (@dangebremedhin) is a partner at Flare Capital Partners, a...
June 18, 2019
This week, Sens. Amy Klobuchar (D-Minn.) and Lisa Murkowski (R-Alaska) introduced legislation to strengthen privacy and security protections for consumers’ personal health data, specifically the data involved in DNA testing kits and health tracking apps.
The Protecting Personal Health Data Act would require HHS to create standards to protect the sensitivity of genetic data,...
June 13, 2019
Genome Medical — a company that offers patient-facing virtual visits and provider-facing consultations with genetic experts — has raised $23 million in Series B funding. The round brings Genome Medical to $46 million in total funding.
The round was led by Echo Health Ventures, with participation from LRVHealth, Casdin Capital, Perceptive Advisors, Manatt Venture Fund and Dreamers Fund, as well as...
May 20, 2019
MyHeritage, an Israeli company that has been doing ancestry-related genetic testing since 2016, has announced a new product that brings the company into the health-focused consumer DNA testing space alongside the likes of 23andMe.
MyHeritage DNA Health+Ancestry is a single test that includes a wide-range of genetic aptitudes for possible health conditions: specifically, the company will offer 11...
February 19, 2019
Emedgene, a startup that employs artificial intelligence to interpret genetic data, has closed a $6 million round led by OliveTree Ventures.
What they do
Trained using data from patient cases, publications and genomics databases, Emedgene’s decision support engine can identify and highlight clinically relevant genetic variants for the provider. The platform is supported by a digital workbench...
October 31, 2018
Yesterday afternoon the FDA announced that it would permit 23andMe to market its Personal Genome Service Pharmacogenetic Reports test. The test offers consumers information on whether they posses one of 33 variants across multiple genes that could impact their body’s ability to metabolize certain medications.
The purpose of this test is to inform patients and encourage them to more thoroughly...
May 31, 2018
Researchers at the University of Pennsylvania School of Medicine have found that telemedicine services could lead to an increase in genetic counseling in community care centers, according to an abstract that will be presented tomorrow at the American Society of Clinical Oncology's annual meeting.
Seventy-seven percent of participants in the study's remote group, who were offered genetic...